MRT (TSE:6034) Cyclically Adjusted Revenue per Share: 円715.65 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6034 MRT Inc TSE:6034
63 GF Score
Price 円631.00
GF Value 円622.71
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is MRT Cyclically Adjusted Revenue per Share?

MRT TSE:6034 +0.16% 63 Cyclically Adjusted Revenue per Share is 円715.65 as of Mar. 2026. GuruFocus rates TSE:6034 with a GF Score™ of 63/100 and a GF Value™ of 円622.71 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

MRT's adjusted revenue per share for the three months ended in Mar. 2026 was 円164.637. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円715.65 for the trailing ten years ended in Mar. 2026.

During the past 12 months, MRT's average Cyclically Adjusted Revenue Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-07), MRT's current stock price is 円631.00. MRT's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円715.65. MRT's Cyclically Adjusted PS Ratio of today is 0.88.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of MRT was 1.63. The lowest was 0.86. And the median was 1.03.


MRT  (TSE:6034) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

MRT's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=631.00/715.65
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of MRT was 1.63. The lowest was 0.86. And the median was 1.03.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


MRT Cyclically Adjusted Revenue per Share Related Terms


MRT Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for MRT's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MRT Cyclically Adjusted Revenue per Share Chart

MRT Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 706.44

MRT Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 652.58 676.43 688.71 706.44 715.65

TSE:6034 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, MRT's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MRT Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MRT's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where MRT's Cyclically Adjusted PS Ratio falls into.


TSE:6034
63GF Score
MRT Inc TSE:6034
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MRT Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MRT's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=164.637/112.7000*112.7000
=164.637

Current CPI (Mar. 2026) = 112.7000.

MRT Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 40.115 97.900 46.179
201606 51.098 98.100 58.703
201609 45.150 98.000 51.923
201612 51.794 98.400 59.321
201703 54.198 98.100 62.264
201706 69.218 98.500 79.197
201709 82.020 98.800 93.559
201712 72.771 99.400 82.508
201803 64.942 99.200 73.780
201806 124.906 99.200 141.904
201809 81.992 99.900 92.497
201812 96.192 99.700 108.735
201903 88.379 99.700 99.903
201906 125.086 99.800 141.254
201909 106.268 100.100 119.644
201912 115.345 100.500 129.347
202003 103.931 100.300 116.780
202006 127.977 99.900 144.374
202009 113.665 99.900 128.229
202012 113.660 99.300 128.998
202103 95.763 99.900 108.033
202106 199.573 99.500 226.049
202109 289.074 100.100 325.461
202112 216.894 100.100 244.195
202203 418.516 101.100 466.536
202206 557.658 101.800 617.368
202209 276.928 103.100 302.714
202212 313.501 104.100 339.400
202303 317.070 104.400 342.278
202306 270.018 105.200 289.268
202309 203.542 106.200 216.000
202312 194.467 106.800 205.210
202403 172.172 107.200 181.005
202406 235.621 108.200 245.420
202412 0.000 110.700 0.000
202503 174.491 111.100 177.004
202506 234.398 111.700 236.496
202509 166.123 112.000 167.161
202512 164.677 113.000 164.240
202603 164.637 112.700 164.637

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円715.65 mean?
MRT (TSE:6034) has a Cyclically Adjusted Revenue per Share of 円715.65 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on MRT and its competitors.
Is MRT's Cyclically Adjusted Revenue per Share too high?
MRT's current Cyclically Adjusted Revenue per Share is 円715.65. Overall, MRT has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's Cyclically Adjusted Revenue per Share compare to HCA and THC?
MRT's Cyclically Adjusted Revenue per Share of 円715.65 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on MRT and its competitors. MRT's current Cyclically Adjusted Revenue per Share is 円715.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円622.71, compared to a current price of 円631.00 — trading 1.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円715.65. MRT's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For MRT (TSE:6034), the current Cyclically Adjusted Revenue per Share is 円715.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MRT (TSE:6034) Overvalued in 2026?

Based on GuruFocus' analysis, MRT stock appears to be overvalued. The current stock price of 円631.00 is trading 1.3% above its estimated GF Value™ of 円622.71. GuruFocus considers MRT to be Fairly Valued.

Key valuation signals for TSE:6034:

  • Cyclically Adjusted Revenue per Share: 円715.65
  • GF Value™: 円622.71 vs. price of 円631.00 (1.3% above fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MRT Business Description

Address 1-18-2 Jinnan, 3rd Floor, Frame Jinnanzaka, Shibuya-ku, Tokyo, JPN, 150-0041
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
63GF Score

Get the complete analysis for TSE:6034

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円631.00
Price
円622.71
GF Value